Bayer stops blood thinner drug trial for lack of effect in major setback, World News - AsiaOne

Germany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug for lack of efficacy, dealing a fresh blow to the embattled drugmaker and throwing its most promising medium-term development project in doubt. It said in a statement late on Sunday that experimental anticoagulant asundexian, which it had hoped would generate annual sales of more than 5 billion

5 Reasons Why Crypto Investors Are Bullish on InQubeta (QUBE), Business News - AsiaOne

Google Chrome now gives out badges to extensions that respect user privacy, Digital News - AsiaOne

iMEDISYNC UNVEILS WORLD'S FIRST INTEGRATED WIRELESS BRAIN EEG at CES 2022, Business News - AsiaOne

Philippines' Marcos says Myanmar a difficult problem for Asean, Asia News - AsiaOne

Duchess Meghan sought advice from senior royals before writing letter to father, World News - AsiaOne

DHL Global Forwarding Asia Pacific certified as Top Employer 2022 third time in a row, Business News - AsiaOne

Woman falls sick after taking ivermectin, HSA probing illegal distribution of drug, Singapore News - AsiaOne

Blood Thinners Recalled Over Cancer-Causing Impurity

Taliban stopped 100 women flying to Dubai for university scholarships, UAE billionaire says, Asia News - AsiaOne